Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03607552 · ClinicalTrials.gov registry record
Non-contrast DWI for Supplemental Screening
A clinical trial of Breast Cancer, sponsored by University of Washington.
- Active
- Registry status
- 269
- Enrollment target
- 2
- Study locations
NCT03607552 is a study of Breast Cancer that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 269 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03607552, a study of Breast Cancer, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- 269 participants
- Enrollment target
- 2
- Study locations
Study Summary
Diffusion-weighted imaging (DWI) is a short (under 5 minutes) non-contrast MRI technique that has shown promise for the detection and characterization of breast cancer. Our preliminary data has shown that DWI holds potential for detecting mammographically and clinically-occult breast cancers. However, current technical limitations reduce the sensitivity of DWI for screening applications. The identification of a screening tool to complement mammography that is more accurate than ultrasound and faster, less expensive, and safer than conventional contrast-enhanced MRI would have significant clinical impact by improving the early detection of cancer in women with dense breasts. We hypothesize that an optimized DWI approach will enable detection of mammographically occult breast cancer in women with dense breasts with high sensitivity and low false positive rate.
Conditions Studied
Interventions
- DEVICE Non-contrast DWI
- DEVICE Non-contrast MRI
Study Locations (2)
Oregon
- Oregon Health & Science University - Portland
Washington
- Seattle Cancer Care Alliance - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2029-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03607552
The ClinicalTrials.gov registry entry for NCT03607552 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 269 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Non-contrast DWI is the first listed.
NCT03607552 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Oregon, Washington.
Frequently Asked Questions
What is clinical trial NCT03607552 about?
NCT03607552 is a clinical study titled "Non-contrast DWI for Supplemental Screening". Diffusion-weighted imaging (DWI) is a short (under 5 minutes) non-contrast MRI technique that has shown promise for the detection and characterization of breast cancer. Our preliminary data has shown that DWI holds potential for detecting mammographically and clinically-occult breast cancers. Howeve...
What is the current status of trial NCT03607552?
This trial is currently active not recruiting. The enrollment target is 269 participants. The study started on 2018-07-16. Estimated completion is 2029-07.
What conditions does trial NCT03607552 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT03607552?
The interventions under investigation include: Non-contrast DWI (DEVICE), Non-contrast MRI (DEVICE).
Who is sponsoring clinical trial NCT03607552?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03607552 being conducted?
This trial has 2 study locations across Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.